Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shari Pilon-Thomas

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
BMC Cancer|June 30, 2021
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumorsPatrick Innamarato, Jennifer Morse, Amy Mackay, et al.
Cytotherapy|September 7, 2024
Expansion of tumor-infiltrating and marrow-infiltrating lymphocytes from pediatric malignant solid tumorsJonathan Metts, Madeline Rodriguez-Valentin, Jonathan Hensel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Scientific Reports|June 23, 2018
Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapyRachel Walker, Jan Poleszczuk, Shari Pilon-Thomas, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Oncotarget|May 14, 2016
Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1Hao Liu, Pasquale Patrick Innamarato, Krithika Kodumudi, et al.
JCO Clinical Cancer Informatics|April 10, 2019
Immunologic Consequences of Sequencing Cancer Radiotherapy and SurgeryJuan Carlos López Alfonso, Jan Poleszczuk, Rachel Walker, et al.
Vaccines|November 24, 2022
Long-Term CD4<sup>+</sup> T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort StudyCorey Gallen, Christopher W Dukes, Amy Aldrich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo Nicolaci, Kim C Tran, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
BMC Cancer|June 30, 2021
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumorsPatrick Innamarato, Jennifer Morse, Amy Mackay, et al.
Cytotherapy|September 7, 2024
Expansion of tumor-infiltrating and marrow-infiltrating lymphocytes from pediatric malignant solid tumorsJonathan Metts, Madeline Rodriguez-Valentin, Jonathan Hensel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Scientific Reports|June 23, 2018
Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapyRachel Walker, Jan Poleszczuk, Shari Pilon-Thomas, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder CancersKayode D Olumoyin, Ahmet Murat Aydin, Sarah Bazargan, et al.
Oncotarget|May 14, 2016
Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1Hao Liu, Pasquale Patrick Innamarato, Krithika Kodumudi, et al.
JCO Clinical Cancer Informatics|April 10, 2019
Immunologic Consequences of Sequencing Cancer Radiotherapy and SurgeryJuan Carlos López Alfonso, Jan Poleszczuk, Rachel Walker, et al.
Vaccines|November 24, 2022
Long-Term CD4<sup>+</sup> T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort StudyCorey Gallen, Christopher W Dukes, Amy Aldrich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell TherapyPatrick Innamarato, Krithika Kodumudi, Sarah Asby, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo Nicolaci, Kim C Tran, et al.
Pageof 11